FLINT, Mich. (AP) _ Diplomat Pharmacy Inc. (DPLO) on Tuesday reported a fourth-quarter loss of $1.1 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Flint, Michigan-based company said it had a loss of 2 cents. Earnings, adjusted for costs related to mergers and acquisitions, came to 8 cents per share.
The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of 16 cents per share.
The independent specialty pharmacy posted revenue of $1.14 billion in the period, which also missed Street forecasts. Five analysts surveyed by Zacks expected $1.15 billion.
For the year, the company reported profit of $28.3 million, or 42 cents per share. Revenue was reported as $4.41 billion.
Diplomat Pharmaceuticals expects full-year earnings in the range of 54 cents to 70 cents per share, with revenue in the range of $4.3 billion to $4.7 billion.
Diplomat Pharmaceuticals shares have increased 7.5 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $13.55, a fall of 62 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DPLO at https://www.zacks.com/ap/DPLO
Keywords: Diplomat Pharmaceuticals, Earnings Report